Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
published in: Journal of Clinical Oncology
date of publication: 2008-01-01
language: English
main subject: California, phase II clinical trial, bevacizumab, ovarian cancer
Cites articles
There is nothing here
Article - wd:Q46114146